The Pew Charitable Trusts named 22 early-career researchers in the US as its Pew Scholars in the Biomedical Sciences today. Each will receive $240,000 over four years to pursue the research of their choice without restriction.
According to the charitable organization, the recipients' research foci explore a range of human health issues "from antibiotic-resistant infections to liver disease and cancer."
Among the 22 newly named scholars are the University of Utah's Nels Elde, whose research focuses on evolutionary genetics and cell biology, Duke University Medical Center's Donald Fox, who studies tissue repair and genome stability, Salil Lachke at the University of Delaware, who works on developmental genetics, Brown University's Sohini Ramachandran, whose research focuses on human genomics and evolution, University of Pennsylvania's Kathryn Wellen, who investigates cancer metabolism and epigenetics, Saint Louis University's Mee-Ngan Yap, who works on molecular microbiology, and Wenjun Zhang at the University of California, Berkeley, who is researching chemical and synthetic biology.
"During these challenging budgetary times when traditional sources of funding are becoming even harder for scientists to obtain, we are proud to back our country's most promising scientists," Pew Charitable Trusts President and CEO Rebecca Rimel says in a statement. "This funding comes at points in the scholars' professional lives when they often are the most innovative. While this program is a bold investment for us, it has paid incalculable dividends due to our scholars' record of producing groundbreaking research."